AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Comera Life Sciences Holdings, Inc.

$0 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0
Market Cap
3.07K
AVG Volume
948
Trailing/Forward PE
-0/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
0100K200K300K400K21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
CMRA Revenue (USD) by quarter
PeriodRevenue (USD)
23 Q3136.31K
23 Q2315.06K
23 Q1392.92K
22 Q4156.12K
22 Q3234.92K
22 Q2146.73K
22 Q195.33K
21 Q473.33K
21 Q387.77K
21 Q270.92K
Net Income (USD)
-10M-7.5M-5M-2.5M021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
CMRA Net Income (USD) by quarter
PeriodNet Income (USD)
23 Q3-2.15M
23 Q2-1.41M
23 Q1-2.48M
22 Q4-2.96M
22 Q3-3.08M
22 Q2-9.09M
22 Q1-2.88M
21 Q4-2.02M
21 Q3-913.7K
21 Q2-1.98M
Operating Income (USD)
-4M-3M-2M-1M021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
CMRA Operating Income (USD) by quarter
PeriodOperating Income (USD)
23 Q3-2.16M
23 Q2-1.48M
23 Q1-2.5M
22 Q4-3.01M
22 Q3-2.54M
22 Q2-3.97M
22 Q1-2.45M
21 Q4-2.02M
21 Q3-913.7K
21 Q2-1.9M
EBITDA (USD)
-10M-7.5M-5M-2.5M021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
CMRA EBITDA (USD) by quarter
PeriodEBITDA (USD)
23 Q3-2.12M
23 Q2-1.38M
23 Q1-2.45M
22 Q4-2.93M
22 Q3-3.04M
22 Q2-9.06M
22 Q1-2.85M
21 Q4-2.08M
21 Q3-894.54K
21 Q2-1.96M
Cash Flows (USD)
-40M-30M-20M-10M021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
CMRA Cash Flows (USD) by quarter
PeriodCash Flows (USD)
23 Q3-1.91M
23 Q2-999.15K
23 Q1-1.99M
22 Q4-30.43M
22 Q3-2.41M
22 Q2-2.67M
22 Q1-2.87M
21 Q4-1.73M
21 Q3-945.19K
21 Q2-729.91K
EPS (USD)
-1.5-1-0.5021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
CMRA EPS (USD) by quarter
PeriodEPS (USD)
23 Q3-0.1
23 Q2-0.08
23 Q1-0.13
22 Q4-0.18
22 Q3-0.2
22 Q2-1.14
22 Q1-0.15
21 Q4-0.11
21 Q3-0.05
21 Q2-0.1
Expenses (USD)
-10M010M20M30M40MR&DSG&ACapex21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
CMRA Expenses (USD) by quarter
PeriodExpenses (USD)
23 Q32.25M
23 Q21.74M
23 Q12.87M
22 Q431.7M
22 Q32.73M
22 Q24.07M
22 Q12.5M
21 Q42.19M
21 Q3964.57K
21 Q21.92M
Cash & Debt (USD)
02M4M6M8MCashLong Term DebtShort Term Debt21 Q121 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
CMRA Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
23 Q31.77M
23 Q2476.3K
23 Q11.54M
22 Q4446.61K
22 Q32.67M
22 Q24.94M
22 Q13.86M
21 Q46.51M
21 Q3450.56K
21 Q1155.43K
Debt ratios
-2.502.557.51021 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
CMRA Debt ratios by quarter
PeriodDebt ratios
23 Q30.18
23 Q2-0.03
23 Q10.07
22 Q4-0.02
22 Q30.08
22 Q20.3
22 Q10.46
21 Q49.26
Margins
0%25%50%75%100%21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
CMRA Margins by quarter
PeriodMargins
23 Q369.22%
23 Q282.21%
23 Q170.34%
22 Q467.74%
22 Q374.05%
22 Q262.83%
22 Q153.3%
21 Q446.91%
21 Q344.9%
21 Q218.82%
Return on Capital
-500%-250%0%250%500%750%21 Q121 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
CMRA Return on Capital by quarter
PeriodReturn on Capital
23 Q351.03%
23 Q222.23%
23 Q147.13%
22 Q447.42%
22 Q389.76%
22 Q2506.97%
22 Q116.84%
21 Q413.78%
21 Q3-0.93%
21 Q1-351.12%
Shares Outstanding
010M20M30M21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
CMRA Shares Outstanding by quarter
PeriodShares Outstanding
23 Q323.11M
23 Q219.15M
23 Q119.03M
22 Q416.69M
22 Q316.02M
22 Q28.14M
22 Q119.09M
21 Q419.09M
21 Q319.09M
21 Q219.09M
Book Value Per Share (USD)
-2024621 Q121 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
CMRA Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
23 Q3-0.18
23 Q2-0.33
23 Q1-0.28
22 Q4-0.37
22 Q3-0.21
22 Q2-0.22
22 Q1-0.9
21 Q4-0.77
21 Q35.15
21 Q10.01
Total Assets (USD)
050M100M150M21 Q121 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
CMRA Total Assets (USD) by quarter
PeriodTotal Assets (USD)
23 Q33.07M
23 Q22.34M
23 Q13M
22 Q43.73M
22 Q34.94M
22 Q26.13M
22 Q14.96M
21 Q47.42M
21 Q3107.68M
21 Q1108.08M
Employee Count
0510152022
CMRA Employee Count by quarter
PeriodEmployee Count
202212
Free Cash Flow Yield
-200000000%-150000000%-100000000%-50000000%0%med -1528873.15%Jan 25May 25Sep 25Jan 26May 26Sep 26
CMRA Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-1528873.15%
Sep 26-1528873.15%
Aug 26-1528873.15%
Aug 26-1528873.15%
Aug 26-1528873.15%
Aug 26-1528873.15%
Jul 26-1528873.1%
Jul 26-1528873.15%
Jul 26-1528873.15%
Jul 26-152887310.29%
Jul 26-1528873.15%
Jun 26-1528873.15%
Jun 26-1528873.15%
Jun 26-1528873.15%
Jun 26-1528873.15%
May 26-1528873.15%
May 26-1528873.15%
May 26-1528873.15%
May 26-1528873.15%
May 26-1528873.15%
Apr 26-1528873.15%
Apr 26-1528873.15%
Apr 26-1528873.15%
Apr 26-1528873.15%
Mar 26-1528873.15%
Mar 26-1528873.15%
Mar 26-1528873.15%
Mar 26-1528873.15%
Feb 26-1528873.15%
Feb 26-1528873.15%
Feb 26-1528873.15%
Feb 26-1528873.1%
Jan 26-1528873.1%
Jan 26-1528873.15%
Jan 26-1528873.15%
Jan 26-1528873.15%
Jan 26-1528873.15%
Dec 25-1528873.15%
Dec 25-1528873.15%
Dec 25-1528873.15%
Dec 25-1528873.15%
Nov 25-1528873.1%
Nov 25-1528873.15%
Nov 25-1528873.1%
Nov 25-1528873.15%
Oct 25-1528873.1%
Oct 25-1528873.15%
Oct 25-1528873.15%
Oct 25-1528873.15%
Oct 25-1528873.15%
Sep 25-1528873.15%
Sep 25-764436.55%
Sep 25-764436.57%
Sep 25-764436.57%
Aug 25-764436.57%
Aug 25-764436.57%
Aug 25-764436.57%
Aug 25-764436.57%
Aug 25-764436.57%
Jul 25-764436.57%
Jul 25-764436.57%
Jul 25-764436.57%
Jul 25-764436.57%
Jun 25-764436.57%
Jun 25-764436.57%
Jun 25-764436.57%
Jun 25-764436.57%
May 25-764436.57%
May 25-1528873.15%
May 25-1528873.15%
May 25-1528873.1%
May 25-1528873.15%
Apr 25-764436.57%
Apr 25-764436.57%
Apr 25-764436.57%
Apr 25-764436.57%
Mar 25-764436.57%
Mar 25-764436.57%
Mar 25-764436.57%
Mar 25-764436.55%
Feb 25-764436.57%
Feb 25-764436.57%
Feb 25-764436.57%
Feb 25-764436.55%
Jan 25-764436.57%
Jan 25-764436.57%
Jan 25-764436.57%
Jan 25-764436.57%
Jan 25-764436.55%
Dec 24-764436.55%
Dec 24-1528873.15%
Dec 24-1528873.1%
Dec 24-1528873.15%
Nov 24-764436.57%
Nov 24-509624.34%
Nov 24-1528873.15%
Nov 24-1528873.15%
Nov 24-1528873.15%
Oct 24-764436.55%
Oct 24-15288.73%
Price to Sales
00.10.20.3med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
CMRA Price to Sales by quarter
PeriodPrice to Sales
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240.01
Nov 240
Nov 240
Nov 240
Oct 240
Oct 240.23
Price to Book
02505007501000med 436.83Jul 21Aug 21Sep 21Dec 21Jan 22Feb 22Mar 22
CMRA Price to Book by quarter
PeriodPrice to Book
Mar 221.98
Mar 221.98
Mar 221.98
Mar 221.98
Feb 221.97
Feb 221.97
Feb 221.97
Feb 221.97
Jan 221.97
Jan 221.97
Jan 221.97
Jan 221.97
Dec 211.97
Sep 21876.9
Sep 21876.03
Sep 21872.54
Sep 21871.67
Aug 21871.67
Aug 21873.42
Aug 21875.16
Aug 21875.16
Jul 21873.42
Jul 21871.67
Jul 21875.16
Jul 21873.42
Jul 21874.29
Comera Life Sciences Holdings, Inc.
CMRA
Stockpicker

Video analysis: CMRA

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.